Clinical Trials Browser

Phase 2 × Stage I Prostate Adenocarcinoma × bicalutamide × Clear all

NCT03147196 2019-01-22

Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery

Phase 2 Withdrawn

Stage I Prostate Adenocarcinoma